Partner at 2048 Ventures
View Live Interactive Profile →Julie Wolf is a Partner at 2048 Ventures, where the firm's team page says she leads the biotech and healthcare verticals and describes her as an investor in more than 50 startups. Before 2048 Ventures she was Chief Science Officer and a member of the founding investment team at SOSV's IndieBio New York. Before entering investing she worked in scientific research, communications and biotech entrepreneurship. She holds a Ph.D. in Microbiology, Immunology, and Cancer Biology from the University of Minnesota and completed a postdoctoral fellowship at Albert Einstein College of Medicine. She is the named author or co-author of the firm's investment announcements for TwoStep Therapeutics, Tetsuwan Scientific, Kascaid, Nionyx Bio and Nimbus Health. No board seat for her was found in any portfolio-company filing or first-party page, so boardSeats is empty.